Key result
Bioinformatics analysis of GEO datasets identified 48 common differentially expressed genes and eight hub genes (including Fn1, Fbn1, and Tlr4) associated with cardiac hypertrophy.
Why the study?
This study aimed to identify key genes and molecular mechanisms associated with cardiac hypertrophy using bioinformatics analysis.
Identified 8 hub genes associated with cardiac hypertrophy that may serve as potential therapeutic biomarkers or targets.
Hub genes merit functional validation; leaves open any therapeutic role in cardiac hypertrophy.
This study aimed to identify key genes and molecular mechanisms associated with cardiac hypertrophy using bioinformatics analysis. Datasets from the Gene Expression Omnibus (GEO) database were analyzed using the GEO2R tool to identify differentially expressed genes (DEGs) related to cardiac hypertrophy. The top 10 DEGs from two datasets (GSE18801 and GSE47420) were used to generate heatmaps and a volcano plot. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were performed using the DAVID website. The protein interaction data for DEGs were visualized using Cytoscape software. A total of 767 DEGs were identified in GSE18801 and 447 DEGs in GSE47420, with 48 common differential genes named co-DEGs. GO enrichment analysis suggested these co-DEGs were mostly related to extracellular matrix organization, muscle system process, and tissue remodeling. KEGG pathway analysis demonstrated co-DEGs were related to malaria, estrogen signaling pathway, ECM-receptor interaction, and apelin signaling pathway. Eight hub genes were identified, including Fn1, Fbn1, Dcn, Ctgf, Timp1, Lox, Tlr4, and Lcn2. These hub genes might serve as therapeutic potential biomarkers of cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2023) studied Cardiac hypertrophy. Bioinformatics analysis of GEO datasets was evaluated on Differentially expressed genes (DEGs) and hub genes related to cardiac hypertrophy. Bioinformatics analysis of GEO datasets identified 48 common differentially expressed genes and eight hub genes (including Fn1, Fbn1, and Tlr4) associated with cardiac hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: